e-learning
resources
Paris 2018
Sunday, 16.09.2018
ILDs: From bench to bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Prognostic analysis of secondary pulmonary alveolar proteinosis: Inspection by one of the world’s largest data.
H. Ishii (Tokyo, Japan), R. Tazawa (Niigata, Japan), T. Saraya (Tokyo, Japan), Y. Inoue (Osaka, Japan), K. Nakata (Niigata, Japan)
Source:
International Congress 2018 – ILDs: From bench to bedside
Session:
ILDs: From bench to bedside
Session type:
Oral Presentation
Number:
265
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Ishii (Tokyo, Japan), R. Tazawa (Niigata, Japan), T. Saraya (Tokyo, Japan), Y. Inoue (Osaka, Japan), K. Nakata (Niigata, Japan). Late Breaking Abstract - Prognostic analysis of secondary pulmonary alveolar proteinosis: Inspection by one of the world’s largest data.. 265
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Clinical assessment and management of pulmonary alveolar proteinosis: the importance of a reference centre
Source: Annual Congress 2009 - Pulmonary alveolar proteinosis: clearing the Milky Way
Year: 2009
European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey.
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Late Breaking Abstract - A comprehensive analysis of endothelial cell markers in pulmonary fibrosis
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Late Breaking Abstract - Covid-19 management in an Italian Prison. Monitoring of pulmonary function using oscillometry.
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Establishment of the consecutive registration system for pulmonary alveolar proteinosis in Japan: Updated incidence, prevalence and surveillance for intractable cases
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Pulmonary alveolar proteinosis – Gender differences in a 20 cases analysis in a reference institute in Romania
Source: International Congress 2014 – ILDs 3
Year: 2014
Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan
Source: Eur Respir J 2011; 37: 465
Year: 2011
Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR)
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Late Breaking Abstract - Pulmonary embolism in patients admitted by COVID-19. Incidence and features.
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021
Late Breaking Abstract - Small airways dysfunction predicts asthma control and exacerbations: Longitudinal Data from ATLANTIS Study
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Late Breaking Abstract - Characteristics of Post-COVID-19 interstitial lung syndrome in Bronchoalveolar Lavage: Preliminary results.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - COVID-19 epidemic in Respiratory Diseases Unit: partioning analysis and data mining. Results from a single Institution experience.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Late Breaking Abstract - MicroRNA profiling informs on the pulmonary sequelae of COVID-19-induced ARDS
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
Pulmonary alveolar proteinosis: A case report
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013
Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm.
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept